Atorvastatin Neutralizes the Up-Regulation of Thrombospondin-1 Induced by Thrombin in Human Umbilical Vein Endothelial Cells

REFERENCES

• Baenziger N. L., Brodie G. N., Majerus P. W. A thrombin-sensitive protein of human platelet membranes. Proceedings of the National Academy of Sciences of the United States of America 1971; 68: 240–243
   PubMed Web of Science ®Google Scholar
• Boerman M., Burton G. R., Wang J., Fink L. M., McGehee R. E., Hauer-Jensen M. Comparative expression profiling in primary and immortalized endothelial cells: Changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibition. Blood Coagulation and Fibrinolysis 2006; 17: 173–180
   PubMed Web of Science ®Google Scholar
• Bonnefoy A., Hantgan R., Legrand C., Frojmovic M. M. A model of platelet aggregation involving multiple interactions of thrombospondin-1, fibrinogen, and GPIIbIIIa receptor. The Journal of Biological Chemistry 2001; 276: 5605–5612
   PubMed Web of Science ®Google Scholar
• Coughlin S. R. Thrombin signalling and protease-activated receptors. Nature 2000; 407: 258–264
   PubMed Web of Science ®Google Scholar
• Dulak J., Loboda A., Jazwa A., Zagorska A., Dörler J., Alber H., Dichtl W., Weidinger F., Frick M., Jozkowicz A. Atorvastatin affects several angiogenic mediators in human endothelial cells. Endothelium 2005; 12: 233–241
   PubMed Web of Science ®Google Scholar
• Edwards P. A., Ericsson J. Sterols and isoprenoids: Signaling molecules derived from the cholesterol biosynthetic pathway. Annual Reviews of Biochemistry 1999; 68: 157–185
   PubMed Web of Science ®Google Scholar
• Esemuede N., Lee T., Pierre-Paul D., Sumpio B. E., Gahtan V. The role of thrombospondin-1 in human disease. Journal of Surgical Research 2004; 122: 135–142
   PubMed Web of Science ®Google Scholar
• Eto M., Luscher T. F. Modulation of coagulation and fibrinolytic pathways by statins. Endothelium 2003; 10: 35–41
   PubMed Web of Science ®Google Scholar
• Iruela-Arispe M. L., Luque A., Lee N. Thrombospondin modules and angiogenesis. The International Journal of Biochemistry and Cell Biology 2004; 36: 1070–1078
   PubMed Web of Science ®Google Scholar
• Jurk K., Clemetson K. J., de Goot P. G., Brodde M. F., Steiner M., Savion N., Varon D., Sixma J. J., Van Aken H., Kehrel B. E. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): An alternative/backup mechanism to von Willebrand factor. The FASEB Journal 2003; 17: 1490–1492
   PubMed Web of Science ®Google Scholar
• Kaushal V., Kohli M., Mehta P., Mehta J. L. Potential anticancer effects of statins: Fact or fiction?. Endothelium 2003; 10: 49–58
   PubMed Web of Science ®Google Scholar
• Lawler J., Sunday M., Thibert V., Duquette M., George E. L., Rayburn H., Hynes R. O. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. The Journal of Clinical Investigation 1998; 101: 982–992
   PubMed Web of Science ®Google Scholar
• Liao J. K., Laufs U. Pleiotropic effects of statins. Annual Reviews of Pharmacology and Toxicology 2005; 45: 89–118
   PubMed Web of Science ®Google Scholar
• Loboda A., Agnieszka J., Jozkowicz A., Molema G., Dulak J. Angiogenic transcriptome of human microvascular endothelial cells: Effect of hypoxia, modulation by atorvastatin. Vascular Pharmacology 2006; 44: 206–214
   PubMed Web of Science ®Google Scholar
• Martínez-Sales V., Gomez-Lechón M. J., Gilabert J. Characteristics of arachidonic acid metabolism of human endothelial cells in culture. Cytotechnology 1990; 3: 21–29
   PubMedGoogle Scholar
• McLaughlin J. N., Mazzoni M. R., Cleator J. H., Earls L., Perigoto A. L., Brooks J. D., Muldowney J. A.S., Vaughan D. E., Hamm H. E. Thrombin modulates the expression of a set of genes including thrombospondin-1 in human microvascular endothelial cells. The Journal of Biological Chemistry 2005; 280: 22172–22180
   PubMed Web of Science ®Google Scholar
• Ohkawara H., Ishibashi T., Sakamoto T., Sugimoto K., Nagata K., Yokoyama K., Sakamoto N., Kamioka M., Matsuoka I., Fukuhara S., Sugimoto N., Takuwa Y., Maruyama Y. Thrombin-induced rapid geranyl geranylation of RhoA as an essential process for RhoA activation in endothelial cells. The Journal of Biological Chemistry 2005; 280: 10182–10188
   PubMed Web of Science ®Google Scholar
• Park H. J., Kong D., Iruela-Arispe M. L., Begley U., Tang D., Galper J. B. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circulation Research 2002; 91: 143–150
   PubMed Web of Science ®Google Scholar
• Reed M. J., Puolakkainen P., Lane T. F., Dickerson D., Bronstein P., Sage E. H. Differential expression of SPARC and thrombospondin 1 in wound repair: Immunolocalization and in situ hybridization. Journal of Histochemistry and Cytochemistry 1993; 41: 1467–1477
   PubMed Web of Science ®Google Scholar
• Riewald M., Ruf W. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signalling. The Journal of Biological Chemistry 2005; 280: 19808–19814
   PubMed Web of Science ®Google Scholar
• Sargiannidou I., Qiu C., Tuszynski G. P. Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis. Seminars in Thrombosis Hemostasis 2004; 30: 127–136
   PubMed Web of Science ®Google Scholar
• Skaletz-Rorowski A., Walsh K. Statin therapy and angiogenesis. Current Opinion in Lipidology 2003; 14: 599–603
   PubMed Web of Science ®Google Scholar
• Tesfamariam B. The effects of HMG-CoA reductase inhibitors on endothelial cells. American Journal of Cardiovascular Drugs 2006; 6: 115–120
   PubMedGoogle Scholar
• Tolsma S. S., Stack M. S., Bouck N. Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thrombospondin-1. Microvascular Research 1997; 54: 13–26
   PubMed Web of Science ®Google Scholar
• Tong H., Holstein S. A., Hohl R. J. Simultaneous determination of farnesyl and geranyl pyrophosphate levels in culture cells. Analytical Biochemistry 2005; 336: 51–59
   PubMed Web of Science ®Google Scholar
• Trumel C., Plantavid M., Levy-Toledano S., Ragab A., Coen J. P., Aguado E., Malissen B., Payrastre B. Platelet aggregation induced by the C-terminal peptide of thrombospondin-1 requires the docking protein LAT but is largely independent of alphaIIb/beta3. Journal of Thrombosis and Haemostasis 2003; 1: 320–329
   PubMed Web of Science ®Google Scholar
• Urbich C., Dernbach E., Zeiher A. M., Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circulation Research 2002; 90: 737–744
   PubMed Web of Science ®Google Scholar
• Uzony B., Lötzer K., Jahn S., Kramer C., Hildner M., Bretschneider E., Radke D., Beer M., Vollandt R., Evans J. F., Funk C. D., Habenicht A. J.R. Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 2006; 103: 6326–6331
   PubMed Web of Science ®Google Scholar
• Weis M., Heeschen C., Glassford A. J., Cooke J. P. Statins have biphasic effects on angiogenesis. Circulation 2002; 105: 739–745
   PubMed Web of Science ®Google Scholar